UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Swimmers with Down Syndrome Are Healthier and Physically Fit than Their Untrained Peers

Healthcare (Basel), 2023-02, Vol.11 (4), p.482

2023

Volltextzugriff (PDF)

Advances in ischemic stroke treatment: neuroprotective and combination therapies

Expert opinion on emerging drugs, 2007-03, Vol.12 (1), p.97-112

2007

Volltextzugriff (PDF)

In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET)

Nature biotechnology, 2000-06, Vol.18 (6), p.655-660

2000

Volltextzugriff (PDF)

Advances in hemorrhagic stroke therapy: conventional and novel approaches

Expert opinion on emerging drugs, 2007-09, Vol.12 (3), p.389-406

2007

Volltextzugriff (PDF)

Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: Combination studies with the thrombolytic tissue plasminogen activator

Stroke (1970), 2002-05, Vol.33 (5), p.1411-1415

2002

Volltextzugriff (PDF)

Microplasmin: A novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits

Stroke (1970), 2002-09, Vol.33 (9), p.2279-2284

2002

Volltextzugriff (PDF)

Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits

Experimental neurology, 2004, Vol.185 (1), p.154-159

2004

Volltextzugriff (PDF)

Effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model combination studies with tissue plasminogen activator

Stroke (1970), 2002-06, Vol.33 (6), p.1665-1670

2002

Volltextzugriff (PDF)

Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease

Experimental neurology, 2000-12, Vol.166 (2), p.287-297

2000

Volltextzugriff (PDF)

Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases

International Review of Neurobiology, 2001, Vol.46, p.379-397

2001

Volltextzugriff (PDF)

The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke

Stroke (1970), 2002, Vol.33 (1), p.147-152

2002

Volltextzugriff (PDF)

Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia

Stroke (1970), 2001-05, Vol.32 (5), p.1220-1225

2001

Volltextzugriff (PDF)

Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease

Brain research, 1997-11, Vol.777 (1), p.153-160

1997

Volltextzugriff (PDF)

Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors

Brain research, 1993-01, Vol.600 (1), p.49-55

1993

Volltextzugriff (PDF)

Reducing bleeding complications after thrombolytic therapy for stroke: Clinical potential of metalloproteinase inhibitors and spin trap agents

CNS drugs, 2001, Vol.15 (11), p.819-829

2001

Volltextzugriff (PDF)

Effects of intrathecal administration of a cell permeant caspase inhibitor, boc- d-fluoromethylketone (BDFMK), on behavioral deficits following spinal cord ischemia: a dose–response analysis

Brain research, 2003-01, Vol.959 (2), p.183-190

2003

Volltextzugriff (PDF)

Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Vol.3 (2), p.87-94

2003

Volltextzugriff (PDF)

100-m Freestyle Race Analysis of the 5th World Down Syndrome Swimming Championship

Medicine and science in sports and exercise, 2012-05, Vol.44 (5S), p.470-470

2012

Volltextzugriff (PDF)

Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

Experimental Neurology, 1997-06, Vol.145 (2), p.309-321

1997

Volltextzugriff (PDF)

BDNF and trkB mRNA expression in the rat hippocampus following entorhinal cortex lesions

Neuroreport, 1993-02, Vol.4 (2), p.191-194

1993

Volltextzugriff (PDF)

Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus

Neuroreport, 1993-03, Vol.4 (3), p.303-306

1993

Volltextzugriff (PDF)

BDNF and trkB mRNA expression in the hippocampal formation of aging rats

Neurobiology of aging, 1993-03, Vol.14 (2), p.121-126

1993

Volltextzugriff (PDF)

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

Brain research, 1992-01, Vol.569 (1), p.141-145

1992

Volltextzugriff (PDF)

Binding sites for [ 3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices

Brain research, 1989-09, Vol.496 (1), p.285-294

1989

Volltextzugriff (PDF)

Direct visualization of brain M2 muscarinic receptors using the selective antagonist [3H]AF-DX116

European journal of pharmacology, 1987-12, Vol.144 (3), p.417-419

1987

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(113)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(55)
Animals
(54)
Neurosciences & Neurology
(30)
Male
(26)
Biological And Medical Sciences
(25)
Rats
(24)
Neurosciences
(23)
Humans
(22)
Fundamental And Applied Biological Sciences. Psychology
(13)
Medical Sciences
(12)
Central Nervous System
(11)
Female
(11)
Vertebrates: Nervous System And Sense Organs
(11)
Brain - Metabolism
(10)
Disease Models, Animal
(10)
Neurology
(9)
Pharmacology & Pharmacy
(9)
Stroke - Drug Therapy
(9)
Autoradiography
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Swimmers with Down Syndrome Are Healthier and Physically Fit than Their Untrained Peers

Advances in ischemic stroke treatment: neuroprotective and combination therapies

In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET)

Advances in hemorrhagic stroke therapy: conventional and novel approaches

Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: Combination studies with the thrombolytic tissue plasminogen activator

Microplasmin: A novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits

Comparison of Tenecteplase with Alteplase on clinical rating scores following small clot embolic strokes in rabbits

Effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model combination studies with tissue plasminogen activator

Deficits in Striatal Dopamine D2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease

Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases

The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke

Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia

Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease

Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors

Reducing bleeding complications after thrombolytic therapy for stroke: Clinical potential of metalloproteinase inhibitors and spin trap agents

Effects of intrathecal administration of a cell permeant caspase inhibitor, boc- d-fluoromethylketone (BDFMK), on behavioral deficits following spinal cord ischemia: a dose–response analysis

Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke

100-m Freestyle Race Analysis of the 5th World Down Syndrome Swimming Championship

Pharmacological Activities of Glial Cell Line-Derived Neurotrophic Factor (GDNF): Preclinical Development and Application to the Treatment of Parkinson's Disease

BDNF and trkB mRNA expression in the rat hippocampus following entorhinal cortex lesions

Interleukin-2 regulates monoamine and opioid peptide release from the hypothalamus

BDNF and trkB mRNA expression in the hippocampal formation of aging rats

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

Binding sites for [ 3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices

Direct visualization of brain M2 muscarinic receptors using the selective antagonist [3H]AF-DX116

Aktive Filter

Suchergebnisse filtern